Two Sigma Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,529
| Closed | -$511K | – | 2063 |
|
|
2025
Q4 | $511K | Sell |
20,529
-46,492
| -69% | -$1.17M | 0.07% | 384 |
|
|
2025
Q3 | $1.71M | Buy |
+67,021
| New | +$1.65M | 0.25% | 76 |
|
|
2025
Q1 | – | Sell |
-50,910
| Closed | -$1.35M | – | 2023 |
|
|
2024
Q4 | $1.35M | Buy |
50,910
+37,146
| +270% | +$1.01M | 0.18% | 105 |
|
|
2024
Q3 | $398K | Buy |
13,764
+2,464
| +22% | +$71.9K | 0.01% | 1504 |
|
|
2024
Q2 | $316K | Sell |
11,300
-297,528
| -96% | -$8.19M | ﹤0.01% | 1944 |
|
|
2024
Q1 | $8.57M | Sell |
308,828
-357,829
| -54% | -$9.93M | 0.08% | 264 |
|
|
2023
Q4 | $19.2M | Buy |
666,657
+269,678
| +68% | +$8.15M | 0.19% | 112 |
|
|
2023
Q3 | $13.2M | Buy |
396,979
+277,100
| +231% | +$9.8M | 0.14% | 145 |
|
|
2023
Q2 | $4.4M | Buy |
119,879
+113,206
| +1,696% | +$4.41M | 0.07% | 328 |
|
|
2023
Q1 | $272K | Buy |
+6,673
| New | +$288K | 0.01% | 1798 |
|
|
2022
Q4 | – | Sell |
-117,094
| Closed | -$5.61M | – | 3097 |
|
|
2022
Q3 | $5.12M | Buy |
117,094
+109,587
| +1,460% | +$5.33M | 0.16% | 146 |
|
|
2022
Q2 | $394K | Sell |
7,507
-869
| -10% | -$44.3K | 0.01% | 1078 |
|
|
2022
Q1 | $434K | Sell |
8,376
-78,446
| -90% | -$4.07M | 0.02% | 1109 |
|
|
2021
Q4 | $5.13M | Buy |
+86,822
| New | +$4.3M | 0.22% | 39 |
|
|
2021
Q3 | – | Sell |
-38,456
| Closed | -$1.7M | – | 1834 |
|
|
2021
Q2 | $1.51M | Buy |
38,456
+20,337
| +112% | +$791K | 0.05% | 307 |
|
|
2021
Q1 | $656K | Buy |
+18,119
| New | +$643K | 0.04% | 231 |
|
|
2020
Q4 | – | Sell |
-9,000
| Closed | -$330K | – | 1872 |
|
|
2020
Q3 | $313K | Sell |
9,000
-18,623
| -67% | -$653K | 0.01% | 838 |
|
|
2020
Q2 | $857K | Sell |
27,623
-778
| -3% | -$26.4K | 0.02% | 443 |
|
|
2020
Q1 | $880K | Buy |
+28,401
| New | +$968K | 0.02% | 424 |
|
|
2019
Q4 | – | Sell |
-32,867
| Closed | -$1.17M | – | 2573 |
|
|
2019
Q3 | $1.12M | Buy |
32,867
+24,231
| +281% | +$881K | 0.01% | 825 |
|
|
2019
Q2 | $355K | Buy |
+8,636
| New | +$343K | ﹤0.01% | 1358 |
|
|
2019
Q1 | – | Sell |
-10,177
| Closed | -$408K | – | 2282 |
|
|
2018
Q4 | $421K | Sell |
10,177
-9,821
| -49% | -$408K | 0.01% | 1101 |
|
|
2018
Q3 | $836K | Sell |
19,998
-30,997
| -61% | -$1.19M | 0.01% | 1117 |
|
|
2018
Q2 | $1.75M | Sell |
50,995
-12,784
| -20% | -$437K | 0.01% | 1013 |
|
|
2018
Q1 | $2.15M | Buy |
63,779
+44,491
| +231% | +$1.53M | 0.01% | 827 |
|
|
2017
Q4 | $663K | Buy |
+19,288
| New | +$658K | 0.02% | 570 |
|
|
2017
Q3 | – | Sell |
-19,319
| Closed | -$616K | – | 1154 |
|
|
2017
Q2 | $616K | Sell |
19,319
-48,961
| -72% | -$1.54M | 0.12% | 160 |
|
|
2017
Q1 | $2.22M | Buy |
68,280
+24,313
| +55% | +$767K | 0.43% | 35 |
|
|
2016
Q4 | $1.35M | Buy |
43,967
+14,265
| +48% | +$435K | 0.45% | 32 |
|
|
2016
Q3 | $954K | Buy |
29,702
+18,619
| +168% | +$623K | 0.33% | 67 |
|
|
2016
Q2 | $370K | Sell |
11,083
-28,497
| -72% | -$909K | 0.2% | 145 |
|
|
2016
Q1 | $1.11M | Buy |
39,580
+28,549
| +259% | +$815K | 1.43% | 7 |
|
|
2015
Q4 | $338K | Buy |
+11,031
| New | +$347K | 0.41% | 53 |
|
|
2015
Q2 | – | Sell |
-7,030
| Closed | -$232K | – | 242 |
|
|
2015
Q1 | $232K | Buy |
+7,030
| New | +$224K | 0.24% | 100 |
|
Other funds holding PFE
VCM
VPM
Two Sigma Securities's PFE Position: Q1 2026 in Review
Two Sigma Securities sold out of Pfizer (PFE) in Q1 2026, closing a stake of 20,529 shares — an estimated $511K sold.
Two Sigma Securities first reported a position in PFE in Q1 2015 and held it in 34 quarters. The position peaked at $19.2M in Q4 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Two Sigma Securities reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 20,529 Pfizer shares in Q1 2026, an estimated $511K.
- Two Sigma Securities first reported a position in Pfizer in Q1 2015 and held it in 34 quarters.
- Two Sigma Securities's Pfizer position peaked at $19.2M in Q4 2023.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.